nach oben

Erschienen in:

05.10.2022 | Congress Report ASCO, EHA 2022

A GLOBAL CONGRESS DIGEST ON TARGETED AND IMMUNE-DIRECTED THERAPIES IN HAEMATOLOGICAL MALIGNANCIES. Report from the American Society of Clinical Oncology (ASCO) Annual Meeting (hybrid), 2nd–6th June 2022, and the 30th European Hematology Association (EHA) 2022 Congress (hybrid), 9th–12th June 2022

Einloggen, um Zugang zu erhalten

Titel: A GLOBAL CONGRESS DIGEST ON TARGETED AND IMMUNE-DIRECTED THERAPIES IN HAEMATOLOGICAL MALIGNANCIES. Report from the American Society of Clinical Oncology (ASCO) Annual Meeting (hybrid), 2nd–6th June 2022, and the 30th European Hematology Association (EHA) 2022 Congress (hybrid), 9th–12th June 2022
Publikationsdatum: 05.10.2022
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe Sonderheft 7/2022
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-022-00837-2

Weitere Artikel der Sonderheft 7/2022